Labiotech.eu

News and Trends 10 Aug 2018

UK Biotech Raises €73M to Target DNA Repair in Treating Cancer

Artios Pharma completed a €73M (£65M) Series B financing round to develop cancer treatments that target DNA repair mechanisms. Cancer occurs when cells in part of the body start dividing uncontrollably as a result of damaged or mutated DNA. In collaboration with Cancer Research UK, Artios Pharma is developing cancer treatments that inhibit proteins involved […]

August 10, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 9 Aug 2018

Modulating the Microbiome Could Boost Vaccine Performance

Dutch scientists have found that altering a patient’s microbiome with antibiotics before a vaccination can boost the body’s resulting immune response against rotavirus infection. Rotavirus causes severe vomiting and diarrhea and largely affects children. Over 200,000 children are killed by the virus each year. The rotavirus vaccine is made of weakened strains of the rotavirus, […]

August 9, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 7 Aug 2018

First 3D Placenta Model Helps Study Pregnancy Disorders

Austrian researchers have created a miniature 3D model of the human placenta, which could help us understand the causes of pregnancy complications. The human placenta plays a vital role in maintaining a healthy pregnancy, supplying the fetus with the nutrients and hormones it needs to grow and protecting it from bacterial infections. Researchers at the […]

August 7, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 7 Aug 2018

Update: Seaweed-Derived Treatment for Common Cold Approved in the EU

Update (07/08/2018): Marinomed Biotech has obtained EU approval to sell a nasal spray containing a polymer derived from red seaweed that can trap most common cold viruses to stop them from infecting us. Published on 19/07/2018 Marinomed Biotech’s antiviral treatment, which is derived from seaweed, could be used to treat the cause of respiratory […]

August 7, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 6 Aug 2018

New Gene Therapy Could Treat Cystic Fibrosis With One Dose

A new partnership in the UK will develop a gene therapy for cystic fibrosis that could treat the disease with a single dose. Cystic fibrosis is a genetic disease that causes mucus to build up in a patient’s lungs. As a result, patients suffer from blocked airways and bacterial infections. While treatment advances have increased […]

August 6, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 4 Aug 2018

Linen and Bacteria: The Hidden History of Microbiology

A bioart exhibition explores the essential role that linen has played in the science of microbiology throughout history. Along with beer, linen is one of the oldest biotechnological products. Since its origins in ancient Egypt, bacteria have been responsible for retting, a process in which the linen fibers are separated from the stem of the […]

August 4, 2018 - 5 minutesmins - By Clara Rodríguez Fernández

News and Trends 3 Aug 2018

Precision Antibiotic Improves Outcome of Gut Infections in Phase II

Summit Therapeutics obtained Phase II results showing its antibiotic for C. difficile infections was more effective in reducing the recurrence of the disease than the standard of care. Clostridium difficile is a bacterium that can infect the gut after a patient receives broad spectrum antibiotics. C. difficile infections typically cause diarrhoea and abdominal pain, but […]

August 3, 2018 - 2 minutesmins - By Alexander Burik

Startup Scout 3 Aug 2018

This Biotech Targets the Neuronal Causes of Hearing Loss

Today, we’re in Archamps, France, visiting Pragma Therapeutics, a neuroscience biotech developing drugs to regulate neuronal signalling in hearing loss. Mission: Pragma Therapeutics develops treatments for noise-induced and age-related hearing loss that regulate glutamate levels. Glutamate is the most abundant neurotransmitter in the nervous system and makes nerve cells turn on, or fire. In patients with […]

August 3, 2018 - 2 minutesmins - By Alexander Burik

More News! 2 Aug 2018

Tomato DNA Could Help Uncover Counterfeit Breast Implants

Counterfeit breast implants can harm patients’ health and even threaten their lives. A German research team is using tomato DNA tags to tell the ‘real thing’ apart from frauds. The silicone used in implants need to have a high-quality to prevent silicone from leaking out of the implant. As a result, the silicone used in […]

August 2, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 2 Aug 2018

EMA Temporarily Scales Back Activities to Prepare for Brexit

As a result of Brexit, the European Medicines Agency will suspend some of its activities to prepare for staff cuts and its move from London to Amsterdam next year. As of October 1st, the EMA will cut back on international collaborations, developing guidelines for regulatory approval, and publishing clinical data in order to maintain its […]

August 2, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 1 Aug 2018

London Biotech Raises €47M to Develop First Treatment Against RSV Virus

ReViral will dedicate the funds to run two clinical trials to test whether its antiviral can help patients at high risk from RSV infections. The respiratory syncytial virus (RSV) only causes mild cold symptoms in most people. But for small children and immunosuppressed patients, it can be deadly. “There are at present no approved therapies […]

August 1, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 31 Jul 2018

Recycled Forestry Waste Could Make Cosmetics, Plastics and Biofuel

An EU project is using forestry waste to make 2,3-butanediol, a chemical with a wide range of industrial applications, from perfumes to synthetic rubber and food additives. Rehap, an EU project, has found a way to produce 2,3-butanediol, a chemical building block used in a range of industrial applications, using sugars purified from forestry waste. […]

July 31, 2018 - 2 minutesmins - By Alexander Burik

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us